Abeona Therapeutics (ABEO) Tops Q3 EPS by 17c

Abeona Therapeutics (NASDAQ: ABEO) reported Q3 EPS of ($0.10), $0.17 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Microsoft (MSFT) spreader of 2800 contracts of October 455 puts and October 490 calls
• S&P 500 may pull back before midterms, but Citi says buy the dip